Recombinant Mouse CD30 Ligand/TNFSF8 Protein
R&D Systems, Inc. a Bio-Techne Brand
Key Product Details
Customers also Viewed
Customers also Purchased
Citations for Recombinant Mouse CD30 Ligand/TNFSF8 Protein (3)
Citations are publications that use Bio-Techne products. Selected citations for Recombinant Mouse CD30 Ligand/TNFSF8 Protein include:
Sample Types: Serum
Applications: ELISA DevelopmentS Yoshida et al. (2020), The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice Nat Commun, 11(1):2482.
Sample Types: Whole Cells
Applications: BioassayMahmud et al. (2014), Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells. Nat Immunol, 15(5):473-81.
Sample Types: In Vivo
Applications: In VivoKayamuro H et al. (2009), TNF superfamily member, TL1A, is a potential mucosal vaccine adjuvant. Biochem. Biophys. Res. Commun., 384(3):296-300.
There are no citations that match your criteria.
FAQs for Recombinant Mouse CD30 Ligand/TNFSF8 Protein
This protein datasheet indicates I need to use a cross-linking antibody, Catalog # MAB050, for biological activity. What is this antibody and is it really necessary?
The antibody is directed against a 6x histidine repeat and is recommended for use as a cross-linker of proteins with 6x his-tag. Crosslinking is often used for proteins that require receptor trimerization and can result greater biological activity. R&D Systems Quality Control tests the performance of these proteins in the presence of the cross-linking antibody. Therefore, it is necessary to use this antibody when trying to achieve the same level of specific activity described in the datasheet.